| Contribution title |
Impact on Multiple Inflammatory Axes Drives a High Level of Efficacy to Upadacitinib: Biomarker Analysis from LEVEL-UP, a Phase 3b/4 Head-to-Head Study with Dupilumab |
| Authors |
-
Kilian Eyerich
Albert-Ludwigs-Universität Freiburg
-
Shawn Gaurav Kwatra
University of Maryland School of Medicine, Maryland Itch Center
-
Christopher Bunick
Yale University School of Medicine
-
Bruce Strober
Yale University School of Medicine
-
Yingtao Bi
AbbVie Inc.
-
James Fann
AbbVie Inc.
-
Ayman Grada
AbbVie Inc.
-
Cristina Sancho Sanchez
AbbVie Inc.
-
Ieva Saulite
Kantonsspital St. Gallen KSSG
Presenter
-
Julie Parmentier
AbbVie Inc.
|
| Form of presentation |
Poster |
| Topic |
-
1.1 Inflammatory and immune-mediated dermatoses
|
